# Oxford Technology Management

> Oxford Technology Management is a VC fund backing Biotechnology. See 110 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Oxford, United Kingdom
- Total investments: 110
- Last investment: Feb 2025
- Lead investor: 7%
- Last fund: Dec 2012
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/oxford-technology-management/
- X (Twitter): https://twitter.com/oxfordtechvc
- Website: http://www.oxfordtechnology.com

Oxford Technology Management is a VC fund in Oxford focused on Biotechnology and Health Care. Oxford Technology Management was founded by Lucius Cary, and since 1983 has specialised in making and managing investments in start-up and early stage technology-based businesses with high growth prospects.The OTM team are all scientists or engineers by background, and understanding the technology is the starting point for any investment thatthey may make.The Investment policy of Oxford Technology Management is to construct a portfolio of investments with the following characteristics:unlisted, UK based, technology businesses investments typically in the range of £100,000 - £2,000,000, although it can then invest similar amounts in subsequent rounds in most cases located within easy reach of Oxford to allow a more 'hands on' management strategy It is expected that approximately half of the funds will be invested in early stage companies (those which have achieved some initial sales) and the balance in start-up companies which are at an earlier stage.

## Contacts

5 contacts available for Oxford Technology Management. Shizune tracks 4 team members at Oxford Technology Management. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/oxford-technology-management?utm_source=investor_profile

## Round sizes

| Stage | Round size |
| --- | --- |
| Seed | $33k–$2.2M |
| Series A | $786k–$7.9M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biotechnology | 26 | 24% |
| Health Care | 20 | 18% |
| Software | 16 | 15% |
| Manufacturing | 15 | 14% |
| Medical | 12 | 11% |

79 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 44 | 40% |
| Funding Round | 31 | 28% |
| Series A | 7 | 6% |
| Series B | 4 | 4% |
| Pre-Seed | 2 | 2% |

9 stages tracked in total.

### Country

| Country | Investments | Share |
| --- | --- | --- |
| United Kingdom | 75 | 68% |
| United States | 3 | 3% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Andrea Mica | Director | 0 | https://shizune.co/investors/profile/andrea-mica |
| David Livesley | Non-Executive Chairman | 0 | https://shizune.co/investors/profile/david-livesley |
| Lucius Cary | Founder and Managing Director | 2 | https://shizune.co/investors/profile/lucius-cary |
| Michael Penington | Partner | 0 | https://shizune.co/investors/profile/michael-penington |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| OrganOx | OrganOx Limited was founded in 2008 to exploit normothermic preservation technology invented by Prof Peter Friend and colleagues and further developed by Prof Constantin Coussios at the University of Oxford. | $160M | Venture - Series Unknown | Feb 24, 2025 |  |
| Metacarpal | Metacarpal broke the mould by creating the first bionic yet fully mechanical hand prosthesis. Capable of switching grips yet offering responsive and precise control already familiar to the user, they aim to also supply prosthetics to those most in need in the developing world. | $1.1M | Seed | Aug 27, 2024 |  |
| CryoLogyx | CryoLogyx is an early-stage biotechnology business that develops frozen, ready-to-use cells for drug discovery. Their exclusive technology is transforming cell freezing, storage, and transportation. Innovation ensures the delivery of viable cells and cell therapies in the appropriate format, ready to use whenever our customers require them. | $636.3K | Seed | Mar 18, 2024 |  |
| MitoRx Therapeutics | MitoRx Therapeutics is a biotechnology company developing novel therapeutics that reverse mitochondrial dysfunction. | $5M | Seed | Dec 13, 2023 |  |
| digiLab Solutions Limited | digiLab is an AI company building uncertainty-aware, explainable software for critical industries like fusion energy, defence, sustainability, and advanced infrastructure. Its flagship platform, The Uncertainty Engine, helps organisations explore, reason, and decide with AI they can trust. Combining frontier science with pragmatic delivery, digiLabsupports customers across government and industry, and leads cutting-edge challenge projects through its applied research unit, theLab. | $1.1M | Seed | Jan 31, 2023 |  |
| OxCan | OxCan is a startup that uses machine learning and liquid biopsy for early lung cancer detection. | $3.6M | Seed | Jan 10, 2023 |  |
| MitoRx Therapeutics | MitoRx Therapeutics is a biotechnology company developing novel therapeutics that reverse mitochondrial dysfunction. |  | Seed | Apr 25, 2022 |  |
| digiLab Solutions Limited | digiLab is an AI company building uncertainty-aware, explainable software for critical industries like fusion energy, defence, sustainability, and advanced infrastructure. Its flagship platform, The Uncertainty Engine, helps organisations explore, reason, and decide with AI they can trust. Combining frontier science with pragmatic delivery, digiLabsupports customers across government and industry, and leads cutting-edge challenge projects through its applied research unit, theLab. | $202K | Pre-Seed | Jan 31, 2022 |  |
| OxCan | OxCan is a startup that uses machine learning and liquid biopsy for early lung cancer detection. | $1.8M | Seed | Sep 06, 2021 |  |
| Mach42 | Machine Discovery is a University of Oxford spin-out commercializing new machine learning technology. We leverage proprietary neural network technology to accelerate expensive calculations — and we do it with minimal data and 99.9% fidelity. | $2.1M | Seed | May 05, 2021 |  |

10 of 110 investments shown.

## Co-investors
- [UK Innovation & Science Seed Fund](https://shizune.co/investors/profile/rainbow-seed-fund) — VC Fund, 9 deals together
- [IP Group](https://shizune.co/investors/profile/ip-group-plc) — VC Fund, 5 deals together
- [Longwall Venture](https://shizune.co/investors/profile/longwall-venture-partners) — VC Fund, 5 deals together
- [Oxford Capital](https://shizune.co/investors/profile/oxford-capital-partners) — VC Fund, 5 deals together
- [Hygea VCT](https://shizune.co/investors/profile/hygea-vct) — VC Fund, 4 deals together
- [Development Bank of Wales](https://shizune.co/investors/profile/development-bank-of-wales) — VC Fund, 3 deals together

## Similar investors

### Similar industry
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [ARCH Venture Partners](https://shizune.co/investors/profile/arch-venture-partners) — VC Fund
- [OrbiMed](https://shizune.co/investors/profile/orbimed-advisors) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

### Similar country
- [SFC Capital](https://shizune.co/investors/profile/startup-funding-club) — VC Fund
- [Fuel Ventures](https://shizune.co/investors/profile/fuel-ventures-fund) — VC Fund
- [Business Growth Fund](https://shizune.co/investors/profile/business-growth-fund) — VC Fund

## Featured in investor lists
- [All Investors in United Kingdom](https://shizune.co/investors/investors-united-kingdom)
- [All VC Funds in United Kingdom](https://shizune.co/investors/vc-funds-united-kingdom)
- [Transportation Investors in United Kingdom](https://shizune.co/investors/transportation-investors-united-kingdom)
- [Transportation VC Funds in United Kingdom](https://shizune.co/investors/transportation-vc-funds-united-kingdom)
- [Health Care Investors in United Kingdom](https://shizune.co/investors/health-care-investors-united-kingdom)
- [Health Care VC Funds in United Kingdom](https://shizune.co/investors/health-care-vc-funds-united-kingdom)

## FAQ

### What does Oxford Technology Management invest in?

Oxford Technology Management invests primarily in Biotechnology, Health Care and Software startups, most often at Seed and Funding Round stage. Most of the 110 investments tracked by Shizune back companies in United Kingdom. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is Oxford Technology Management's check size?

Oxford Technology Management typically joins rounds of $33k–$2.2M at Seed and $786k–$7.9M at Series A. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Oxford Technology Management participates in.

### How do I contact Oxford Technology Management?

Public channels for Oxford Technology Management include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Oxford Technology Management?

The team at Oxford Technology Management includes Andrea Mica (Director), David Livesley (Non-Executive Chairman) and Lucius Cary (Founder and Managing Director). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co